Harmony Biosciences (HRMY) Q2 2023 Earnings Call Transcript

HRMY earnings call for the period ending June 30, 2023.

Related Keywords

,Jeff Dierks ,Charles Duncan ,David Amsellem Piper Sandler ,Poorna Kannan Needham ,Corinne Jenkins Goldman Sachs ,Francois Brisebois ,Corinne Jenkins ,Charles Duncan Cantor Fitzgerald ,Kumar Budur ,Jeffrey Dayno ,Graig Suvannavejh Mizuho ,Piper Sandler ,David Amsellem ,Danielle Brill ,Luis Sanay ,Raymond James ,Alex Nackenoff Raymond James ,America Merrill Lynch ,Jeffrey Dierks ,Francois Brisebois Oppenheimer ,Graig Suvannavejh ,Jason Gerberry ,Sandip Kapadia ,Jeff Dayno ,Jason Gerberry Bank ,Symphony Health ,Cantor Fitzgerald ,Company Analyst ,Needham Company ,Goldman Sachs ,Harmony Biosciences ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Ami Fadia ,Scorpion Capital ,